bibliographicCitation |
CHRISTERSSON C, OLDGREN J, BYLOCK A, WALLENTIN L, SIEGBAHN A. Long-term treatment with ximelagatran, an oral direct thrombin inhibitor, persistently reduces the coagulation activity after a myocardial infarction. Journal of Thrombosis and Haemostasis. 2005 Oct;3(10):2245–53. doi: 10.1111/j.1538-7836.2005.01557.x. |